<it>In vitro </it>and <it>in vivo </it>evaluation of NCX 4040 cytotoxic activity in human colon cancer cell lines
<p>Abstract</p> <p>Background</p> <p>Nitric oxide-releasing nonsteroidal antiinflammatory drugs (NO-NSAIDs) are reported to be safer than NSAIDs because of their lower gastric toxicity. We compared the effect of a novel NO-releasing derivate, NCX 4040, with that of aspi...
Main Authors: | Zupi Gabriella, Scarsella Marco, Leonetti Carlo, Rosetti Marco, Fabbri Francesco, Ulivi Paola, Tesei Anna, Amadori Dino, Bolla Manlio, Zoli Wainer |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2005-02-01
|
Series: | Journal of Translational Medicine |
Online Access: | http://www.translational-medicine.com/content/3/1/7 |
Similar Items
-
Study of molecular mechanisms of pro-apoptotic activity of NCX 4040, a novel nitric oxide-releasing aspirin, in colon cancer cell lines
by: Vannini Ivan, et al.
Published: (2007-10-01) -
Zoledronic acid increases docetaxel cytotoxicity through pMEK and Mcl-1 inhibition in a hormone-sensitive prostate carcinoma cell line
by: Silvestrini Rosella, et al.
Published: (2008-08-01) -
Short Interfering RNA Directed against the SLUG Gene Increases Cell Death Induction in Human Melanoma Cell Lines Exposed to Cisplatin and Fotemustine
by: Ivan Vannini, et al.
Published: (2007-01-01) -
Characterization of a novel antibiofilm effect of nitric oxide-releasing aspirin (NCX-4040) on Candida albicans isolates from denture stomatitis patients.
by: Francisco Madariaga-Venegas, et al.
Published: (2017-01-01) -
NCX-4040, a nitric oxide-releasing aspirin, sensitizes drug-resistant human ovarian xenograft tumors to cisplatin by depletion of cellular thiols
by: Ignarro Louis J, et al.
Published: (2008-02-01)